Cronos Group to Exit U.S. CBD Market – Medical Marijuana Program Connection

By Sabela Ojea

Cronos Group said Wednesday it is winding down and exiting U.S. CBD operations by the end of the second quarter to reduce expenses.

The cannabis company aims to directly enter the U.S. THC marihuana market in the U.S. when governmental regulation allows it.

The…